Crestor
Product Images NDC 68151-4634

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 68151-4634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Strucural Formula (3a498c46 5ad2 416a 875e 18e48b586954 01)

Chemical structure diagram of the active ingredient in CRESTOR, illustrating the calcium salt form with detailed atomic connectivity and functional groups.*

FDA Label Image

Figure One (3a498c46 5ad2 416a 875e 18e48b586954 02)

A boxplot chart comparing the percent change from baseline in LDL-C levels for four statin drugs: CRESTOR, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows drug names with corresponding doses in milligrams, while the y-axis shows percent change ranging from -75% to 0%.*

FDA Label Image

Figure Two (3a498c46 5ad2 416a 875e 18e48b586954 03)

A Kaplan-Meier cumulative incidence graph comparing Rosuva and Placebo groups over 5 years. The y-axis shows cumulative incidence percentage, and the x-axis shows years. The chart includes a hazard ratio (HR 0.56, 95% CI 0.46-0.69) and a significance value (P < 0.001). A table below indicates the number at risk at various time points for both groups.*

FDA Label Image

Figure Three (3a498c46 5ad2 416a 875e 18e48b586954 04)

A data table presenting clinical trial endpoints comparing Rosuva 20 mg versus placebo 20 mg in 8901 patients each. It lists number of events, rates, hazard ratios with 95% confidence intervals, P values, and a graphical hazard ratio plot for endpoints including primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization.*

FDA Label Image

Label Image (Lbl681514634)

Label for CRESTOR 5 mg tablets containing rosuvastatin calcium, manufactured by Corden Pharma. The label shows product details including lot number BM0099, expiration date 07/14, and NDC 68151-4634, with a barcode and indication for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.